This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Forward Pharma A/S
Drug Names(s): dimethyl fumarate, BG00012
Description: FP187 is a formulation of dimethyl fumarate (DMF), an oral small molecule that has been used to treat psoriasis since the 1950's. DMF inhibits NFkappaB translocation, which leads to (i) the inhibition of pro-inflammatory cytokine production and adhesion molecule expression, (ii) the inhibition of dendritic cell differentiation and, at higher concentrations, and (iii) the induction of apoptosis.
Additional information available to subscribers only: